Skip to Primary Navigation

Skip to main content

New York attorney general charges former Emergent BioSolutions chief with insider trading

Photo of New York State Attorney General Letitia James standing in front of the seal of the Office of the Attorney General with a blue background.
Photo: Michael M. Santiago/Getty Images
Kevin Kinsella profile image

Kevin Kinsella

1 min read

Robert G Kramer is accused of selling his company shares before publicly revealing contamination issues with his company’s COVID-19 vaccine production.

The Office of the New York Attorney General (OAG) has announced it is suing former Emergent BioSolutions CEO Robert Kramer for insider trading.

The OAG also announced a settlement with Emergent for approving Kramer’s illegal trading plan.

In the summer of 2020, Emergent, which contracts with pharmaceutical

Following

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience